Institute of Biochemistry, Federal Research Center of Fundamental and Translation Medicine, Novosibirsk, Russia.
Biomed Khim. 2024 Aug;70(4):206-217. doi: 10.18097/PBMC20247004206.
Endothelial dysfunction underlies the pathogenesis of many diseases, primarily cardiovascular diseases. Epidemiological studies have shown an inverse dependence between the plasma level of high-density lipoproteins (HDL) and cardiovascular diseases. The results of experimental studies indicate that the antiatherogenic effect of HDL is associated not only with their participation in the reverse transport of excess cholesterol, but also with their regulatory effect on the functions of cells of various organs and tissues, including endothelial cells. The purpose of this review is to consider recent data on the participation of plasma receptors and related intracellular signaling pathways in the mechanism of protective effect of HDL on endothelial cell functions. Understanding the mechanisms of cell function regulation under the influence of HDL is an important step for the development of new ways of pharmacological correction of impaired endothelial functions and creation of effective endothelial protection drugs.
内皮功能障碍是许多疾病(主要是心血管疾病)发病机制的基础。流行病学研究表明,血浆高密度脂蛋白(HDL)水平与心血管疾病呈负相关。实验研究的结果表明,HDL 的抗动脉粥样硬化作用不仅与其参与过量胆固醇的逆向转运有关,还与其对包括内皮细胞在内的各种器官和组织细胞功能的调节作用有关。本综述的目的是考虑关于血浆受体和相关细胞内信号通路参与 HDL 对内皮细胞功能的保护作用机制的最新数据。了解 HDL 影响下细胞功能调节的机制是开发新的药理学纠正受损内皮功能和创造有效内皮保护药物的重要步骤。